Abstract:
:Small heterodimer partner (SHP) plays an essential role in the regulation of innate immune and inflammatory responses. The aim of the present study was to identify whether SHP levels are associated with cancer immunology and treatment outcomes in rectal cancer. SHP expression was analyzed via gene set enrichment analysis and the OncoLnc database. In addition, immunohistochemistry and reverse transcription-quantitative PCR analyses were performed on the tissues of patients with locally advanced rectal cancer, and the associations of SHP expression with the clinicopathological and hematological features or treatment response to preoperative radiochemotherapy (pRCT) were analyzed retrospectively. Furthermore, the present study investigated whether SHP expression correlated with immune infiltration levels and immune checkpoint molecules in rectal cancer. The results revealed that low SHP mRNA expression was significantly associated with an inflammatory response and poor prognosis. The nuclear expression of SHP was associated with clinical N stage, neutrophil count, lymphocyte count, neutrophil-lymphocyte ratio and complete pathologic response following pRCT. The low nuclear expression of SHP was associated with poor overall and distant metastasis-free survival (DMFS). In multivariate analysis, the low nuclear expression of SHP was identified as a significant independent prognostic factor for DMFS and a marginally significant prognostic factor for overall survival in rectal cancer. Furthermore, patients with low SHP expression exhibited higher neutrophil and CD8+ T cell infiltration levels and higher PD-L1 expression in rectal adenocarcinoma. These results indicate that SHP may act as an anti-inflammatory mediator via the regulation of systemic and local immune responses in rectal cancer. Moreover, SHP might be useful a potential marker or therapeutic target in rectal cancer.
journal_name
Oncol Lettjournal_title
Oncology lettersauthors
Kim S,Joo M,Yeo MK,Cho MJ,Kim JS,Jo EK,Kim JMdoi
10.3892/ol.2021.12969keywords:
["cancer-related inflammation","prognosis","radiochemotherapy","rectal cancer","small heterodimer partner"]subject
Has Abstractpub_date
2021-10-01 00:00:00pages
708issue
4eissn
1792-1074issn
1792-1082pii
OL-0-0-12969journal_volume
22pub_type
杂志文章相关文献
Oncology Letters文献大全abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.441
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.417
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.450
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.459
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.503
更新日期:2012-02-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.489
更新日期:2012-02-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.481
更新日期:2012-02-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.502
更新日期:2012-02-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.485
更新日期:2012-02-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.519
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.544
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.526
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.512
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.550
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.577
更新日期:2012-04-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.564
更新日期:2012-04-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.580
更新日期:2012-04-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.584
更新日期:2012-04-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.628
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.619
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.596
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.614
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.654
更新日期:2012-06-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.639
更新日期:2012-06-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.647
更新日期:2012-06-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.643
更新日期:2012-06-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.693
更新日期:2012-07-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.706
更新日期:2012-07-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.671
更新日期:2012-07-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.700
更新日期:2012-07-01 00:00:00